Randa Tao, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Travel
    Ineligible company:
    The Lynx Group
    Topic:
    Travel expenses to attend the annual Cholangiocarcinoma Summit
    Date added:
    07/21/2022
    Date updated:
    07/21/2022
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Helsinn
    Topic:
    Honorarium for participation on a cholangiocarcinoma advisory board
    Date added:
    07/21/2022
    Date updated:
    07/21/2022
    Relationship end date:
    10/29/2021
  • Type of financial relationship:
    Other
    Ineligible company:
    QED Therapeutics
    Topic:
    Honorarium for participation on a cholangiocarcinoma advisory board
    Date added:
    07/21/2022
    Date updated:
    07/21/2022
    Relationship end date:
    10/30/2020
Return to 2022 Cellular Therapy Conference – Translating recent evidence on cellular therapy to real world management of malignancies